1. Pharmacopoeia commission of RPC. Chinese Pharmacopoeia (Part I, 2010 edition). Beijing: China Medical Science Press; 2010. p. 130.
2. Hsu B, Kin KC. Pharmacological study of tetrahydropalmatine and its analogs, a new type of central depressants. Arch Int Pharmacodyn Ther. 1962;139:318–27.
3. Liu GQ, Algeri S, Garattini S. D-L-Tetrahydropalmatine as monoamine depletor. Arch Int Pharmacodyn Ther. 1982;258(1):39–50.
4. Chang CK, Lin MT. DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats. Neurosci Lett. 2001;307(3):163–6.
5. Hsieh MT, Peng WH, Hsieh CC. Effects of DL-tetrahydropalmatine on motor activity and the brain monoamine concentration in rats. Chin J Physiol. 1994;37(2):79–82.